학술논문

COVID-19 and hypogonadism: secondary immune responses rule-over endocrine mechanisms.
Document Type
Article
Source
Human Fertility. Feb2023, Vol. 26 Issue 1, p182-185. 4p.
Subject
*HYPOGONADISM
*COVID-19
*MEN'S health
*IMMUNOGLOBULINS
*SARS-CoV-2
*TESTOSTERONE
*HYPOTHALAMIC-pituitary-gonadal axis
*OXIDATIVE stress
*IMMUNITY
*LUTEINIZING hormone
*ANGIOTENSIN converting enzyme
*ANGIOTENSIN II
*ADRENOCORTICOTROPIC hormone
*DISEASE risk factors
Language
ISSN
1464-7273
Abstract
Men show higher vulnerability to severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection (COVID-19) and present with depleted testosterone levels. Reports pertaining to high luteinizing hormone (LH), while diminished levels of in COVID-19 patients negate the hypothalamic–pituitary–testicular (HPT) axis mediated lowering of testosterone. Although not evidenced, high testicular expression of angiotensin-converting enzymes-2 (ACE2), that aids viral entry into cells, may suggest direct viral-testicular invasion. However, secondary inflammation and oxidative stress (OS), owing to SARS-CoV-2 infection, are more likely to impair steroidogenesis. Moreover, blockage of ACE2 aided angiotensin II into angiotensin (1–7) conversion may also affect testosterone synthesis. SARS-CoV-2, by mimicking adrenocorticotrophic (ACTH) hormones, may trigger host antibodies against the ACTH molecules to suppress host stress response. This commentary concisely presents the possible mechanisms by which SARS-CoV-2 infection may affect testosterone levels, which possibly result in compromised male reproductive health. [ABSTRACT FROM AUTHOR]